Cargando…
COVID-19-associated mucormycosis in India: Why such an outbreak?
An unprecedented mucormycosis outbreak occurred in India during the second COVID-19 wave in spring 2021. COVID-19-associated mucormycosis (CAM) was observed, mainly rhino-orbito-cerebral mucormycosis (ROCM), in patients with poorly controlled diabetes and treated with inappropriate doses of glucocor...
Autor principal: | Pasquier, Gregoire |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SFMM. Published by Elsevier Masson SAS.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10168193/ https://www.ncbi.nlm.nih.gov/pubmed/37182234 http://dx.doi.org/10.1016/j.mycmed.2023.101393 |
Ejemplares similares
-
Multicenter Case–Control Study of COVID-19–Associated Mucormycosis Outbreak, India
por: Muthu, Valliappan, et al.
Publicado: (2023) -
Five probable factors responsible for the COVID-associated mucormycosis outbreak in India
por: Ravindra, Khaiwal, et al.
Publicado: (2021) -
Coincidence or reality behind Mucormycosis, diabetes mellitus and Covid-19 association: A systematic review
por: Sengupta, Indraneel, et al.
Publicado: (2022) -
COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature review
por: Benhadid-Brahmi, Yasmine, et al.
Publicado: (2022) -
Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World
por: Muthu, Valliappan, et al.
Publicado: (2021)